U.S. Food and Drug Administration Updates CAMZYOS ® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications
1 week ago
8
-
Homepage
-
Finance
- U.S. Food and Drug Administration Updates CAMZYOS ® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications